Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagiwa, Y.
Right arrow Articles by Patel, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagiwa, Y.
Right arrow Articles by Patel, T.
[Cancer Research 64, 1293-1298, February 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6

A Novel Mechanism of Tumor Cell Survival

Yoko Yamagiwa1, Carla Marienfeld1, Fanyin Meng1, Martin Holcik2 and Tushar Patel1

1 Scott and White Clinic, Texas A&M University System Health Science Center College of Medicine, Temple, Texas, and 2 Solange Gauthier Karsh Molecular Genetics Laboratory, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada

Interleukin-6 (IL-6) is a pleiotropic cytokine with diverse biological effects. IL-6 has been implicated in autocrine signaling pathways promoting tumor progression and chemoresistance in some human tumors. However, the mechanisms by which IL-6 modulates these responses are unknown. Aberrant apoptosis has been implicated as a fundamental mechanism of chemotherapeutic resistance. Thus, we investigated whether IL-6 alters the expression of apoptosis regulatory proteins as a mechanism of drug resistance. We provide evidence that IL-6 rapidly phosphorylates the translation initiation factor eukaryotic initiation factor-4E and triggers antiapoptotic responses in cholangiocarcinoma cells. Reduction of cellular eukaryotic initiation factor-4E by RNA interference decreases IL-6-induced effects on cytotoxic drug-induced caspase activation and apoptosis. Furthermore, IL-6 increases expression of the endogenous X-linked inhibitor of apoptosis protein expression by translation at an internal ribosome entry site. Our findings that IL-6 translationally regulates X-linked inhibitor of apoptosis protein expression reveal a novel mechanism by which IL-6 mediates tumor cell survival that may be targeted therapeutically to decrease tumor progression and chemoresistance.




This article has been cited by other articles:


Home page
J. Cell Biol.Home page
H. Lelouard, E. K. Schmidt, V. Camosseto, G. Clavarino, M. Ceppi, H.-T. Hsu, and P. Pierre
Regulation of translation is required for dendritic cell function and survival during activation
J. Cell Biol., December 31, 2007; 179(7): 1427 - 1439.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wehbe, R. Henson, F. Meng, J. Mize-Berge, and T. Patel
Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression
Cancer Res., November 1, 2006; 66(21): 10517 - 10524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Slevin, A. B. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, and J. Gaffney
Identification of Differential Protein Expression Associated with Development of Unstable Human Carotid Plaques
Am. J. Pathol., March 1, 2006; 168(3): 1004 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yan, P. Frost, Y. Shi, B. Hoang, S. Sharma, M. Fisher, J. Gera, and A. Lichtenstein
Mechanism by Which Mammalian Target of Rapamycin Inhibitors Sensitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis
Cancer Res., February 15, 2006; 66(4): 2305 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Meng, Y. Yamagiwa, S. Taffetani, J. Han, and T. Patel
IL-6 activates serum and glucocorticoid kinase via p38{alpha} mitogen-activated protein kinase pathway
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C971 - C981.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. E. Eckel-Passow, A. Hoering, T. M. Therneau, and I. Ghobrial
Experimental Design and Analysis of Antibody Microarrays: Applying Methods from cDNA Arrays
Cancer Res., April 15, 2005; 65(8): 2985 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Sherrill, M. P. Byrd, M. E. Van Eden, and R. E. Lloyd
BCL-2 Translation Is Mediated via Internal Ribosome Entry during Cell Stress
J. Biol. Chem., July 9, 2004; 279(28): 29066 - 29074.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A. Vannay, A. Fekete, C. Adori, T. Toth, G. Losonczy, L. Laszlo, B. Vasarhelyi, T. Tulassay, and A. Szabo
Divergence of renal vascular endothelial growth factor mRNA expression and protein level in post-ischaemic rat kidneys
Exp Physiol, July 1, 2004; 89(4): 435 - 444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.